Gough Au

Dr. Gough Au is a Senior Lecturer at the School of Biomedical Sciences and Pharmacy, University of Newcastle, and a Research Director at Viralytics Ltd. His career spans academic research and industry collaboration in oncolytic virotherapy and virology, with affiliations to the University of Newcastle since 2004.

• Education: PhD in Biomedical Sciences, Bachelor of Biomedical Sciences (Hons), University of Newcastle

Research Interests: Specializing in oncolytic virotherapy, Dr. Au develops naturally occurring viruses for treating melanoma, multiple myeloma, and malignant glioma. His work bridges virology, cancer biology, and clinical oncology, with recent focus on SARS-CoV-2 pathogenesis and vaccine testing in ferret models.

Publication Trends: Dr. Au's 15 most recent articles emphasize virology (SARS-CoV-2, Ebola), cancer therapies (pancreatic, bladder, melanoma), and metabolic profiling. Key areas include oncolytic viral mechanisms, host immune responses, and preclinical modeling.

• Scientific Awards: No explicit awards listed

Advising & Grants: Supervised 5 PhD candidates. Secured $595,774 in grants (2007-2011) from NHMRC, Ramaciotti Foundations, and industry partners. Projects included viral cancer therapies, equipment grants, and travel funding for international conferences.

Labs & Teams: Collaborates with researchers across University of Newcastle, Viralytics Ltd, and multi-institutional consortia. Leads studies in virology, immunology, and oncolytic virus development with integrated work in animal models and clinical translation.